Cargando…

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer

Metastatic colorectal cancer (mCRC) relies on the detachment of aggressive malignant cells from the primary tumor into the bloodstream and, concordantly, the presence of these Circulating Tumor Cells (CTC) is associated with a poor prognosis. In this work, the molecular characterization of CTC from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbazán, Jorge, Alonso-Alconada, Lorena, Muinelo-Romay, Laura, Vieito, María, Abalo, Alicia, Alonso-Nocelo, Marta, Candamio, Sonia, Gallardo, Elena, Fernández, Beatriz, Abdulkader, Ihab, de los Ángeles Casares, María, Gómez-Tato, Antonio, López-López, Rafael, Abal, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397799/ https://www.ncbi.nlm.nih.gov/pubmed/22811761 http://dx.doi.org/10.1371/journal.pone.0040476

Ejemplares similares

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer
por: Mariscal, Javier, et al.
Publicado: (2016)

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
por: Muinelo-Romay, Laura, et al.
Publicado: (2014)

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
por: León-Mateos, Luis, et al.
Publicado: (2017)

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
por: Vidal Insua, Yolanda, et al.
Publicado: (2017)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
por: León-Mateos, Luis, et al.
Publicado: (2020)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
por: Rodríguez-Casanova, Aitor, et al.
Publicado: (2021)

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
por: Abreu, Manuel, et al.
Publicado: (2020)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study
por: Zapatero, Almudena, et al.
Publicado: (2020)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis
por: Casas-Arozamena, Carlos, et al.
Publicado: (2021)

Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node
por: Alonso-Nocelo, Marta, et al.
Publicado: (2016)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022)

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
por: Alonso-Alconada, Lorena, et al.
Publicado: (2014)

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
por: Vila, Ana, et al.
Publicado: (2016)

Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report
por: Casas-Arozamena, Carlos, et al.
Publicado: (2022)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer
por: Alonso-Alconada, Lorena, et al.
Publicado: (2020)

Integrity and quantity of salivary cell‐free DNA as a potential molecular biomarker in oral cancer: A preliminary study
por: Rapado‐González, Óscar, et al.
Publicado: (2022)

Extracellular Vesicles’ Genetic Cargo as Noninvasive Biomarkers in Cancer: A Pilot Study Using ExoGAG Technology
por: Herrero, Carolina, et al.
Publicado: (2023)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
por: Brozos-Vázquez, E. M., et al.
Publicado: (2023)

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
por: Rapado-González, Óscar, et al.
Publicado: (2019)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
por: Ribeiro-Samy, Silvina, et al.
Publicado: (2019)

Detection of circulating melanoma cells in choroidal melanocytic lesions
por: Bande, Manuel F., et al.
Publicado: (2015)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer
por: Picardo, Francesco, et al.
Publicado: (2019)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3fdttb0dtvr6ibmhg2pfbtmg9p